Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

ESC guidance for managing cardiovascular disease during COVID-19

Leading experts treating COVID-19 patients provide advice on managing cardiovascular disease during the pandemic.

21 Apr 2020

Air pollution, dementia, and cardiovascular disease

A new study published in March 2020 in the journal JAMA Neurology shows an association between air pollution and the development of dementia. However, the role played by cardiovascular disease (CVD) is yet to become apparent.

21 Apr 2020

Scientists identify new biomarker to detect subclinical atherosclerosis

Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques--accumulations of cholesterol in the wall of arteries--could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.

21 Apr 2020

New consensus on managing AMI patients during COVID-19 released

The Society for Cardiovascular Angiography and Interventions, along with the American College of Cardiology and American College of Emergency Physicians have released a consensus statement that provides recommendations for a systematic approach for the care of patients with an acute myocardial infarction during the coronavirus disease-2019 pandemic.

21 Apr 2020

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

The COVID-19 pandemic has forced clinicians and academicians to intensive research to find evidence for many conventional therapies. A new round-up editorial published in the journal Cardiovascular Research in April 2020 summarizes the current clinical grounds for and against the use of the commonly used angiotensin axis inhibitors in patients with COVID-19.

20 Apr 2020

Smoking doubles risk of severe COVID-19 disease

The fatality rate among infected people increases among the elderly and those with underlying medical conditions. Now, a new study published as a pre-print on medXriv, links smoking to the progression of COVID-19 disease, suggesting that the odds of disease progression is more than double in smokers.

20 Apr 2020

Scientists estimate fatality ratio across full spectrum of COVID-19 disease

A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.

19 Apr 2020

A new approach to predict risk of radiation-induced cancer in astronauts

The National Aeronautics and Space Administration, NASA, aims to send human missions to Mars in the 2030s. But scientists are still trying to learn more about the potential cancer risks for astronauts due to radiation exposure.

17 Apr 2020

Review investigates stem cell therapy as potential new treatment for preeclampsia

Preeclampsia is the leading cause of death and disability, for both mothers and babies, killing approximately 76,000 mothers and 500,000 babies globally every year. Despite this, the only cure at present is to deliver the placenta and the baby, with the potential for long term complications.

16 Apr 2020

Entamoeba gingivalis linked to severe and recurrent periodontitis

For the first time, researchers from Charité - Universitätsmedizin Berlin have shown that a unicellular parasite commonly found in the mouth plays a role in both severe tissue inflammation and tissue destruction.

16 Apr 2020

New grant aims to develop digital tools for assessing patients with cardiovascular disease

A new grant will fund an international collaboration to develop tools to assess patients who suffer from cardiovascular disease.

15 Apr 2020

A talk with your GP may reduce risk of getting cardiovascular disease

Having a general practitioner who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

14 Apr 2020

New insights into the building blocks of periodontitis

Porphyromonas gingivalis is a major bacterial pathogen which leads to periodontitis also known as gum disease. In Japan, 80% of adults aged 35 and over suffer from this disease. What's more, P. gingivalis has also been linked to rheumatoid arthritis, cardiovascular disease, pancreatic cancer, and even Alzheimer's disease.

13 Apr 2020

Exercise enhances muscle-repair capabilities in old mice, Stanford study shows

A nightly jaunt on the exercise wheel enhances muscle-repair capabilities in old mice, according to a new study by researchers at Stanford School of Medicine.

13 Apr 2020

The building blocks of gum disease

A team of researchers has revealed the structure of adhesive pili and shed light on how they assemble, causing Periodontitis.

13 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

New guidance on treating COVID-19 patients with heart attack signs

Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19.

9 Apr 2020

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

9 Apr 2020

GlobalData: Australia’s commitment to support clinical trial ecosystem will benefit medical device sector

Australia is dedicating more government funding towards the establishment of a vibrant clinical trial ecosystem in order to accelerate the design, development, verification and product launch processes of medical devices, says GlobalData, a leading data and analytics company.

9 Apr 2020